Elad Elkayam

Company: Ventus Therapeutics

Job title: Principal Investigator

Seminars:

First-in-Class Caspase-4/5 Inhibition: Unlocking New Frontiers in Inflammasome Therapeutics 10:00 am

Identifying highly selective small-molecule inhibitors of caspase-4/5 via a novel allosteric mechanism Showcasing enhanced cellular potency, suppression of pyroptosis, and IL-18 release across multiple cell types Evaluating clinical pathways and disease indications including IBD and hidradenitis suppurativa for redefined treatment strategiesRead more

day: Conference Day Two AM